Sustained Release Excipients Market Research Report Information By Product Type (Gelatin, Polymers, Minerals, Sugars, and Others), By Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous, and Others), By Technology (Targeted Delivery, Microencapsulation, Wurster Technique, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Gelatin

6.3. Polymers

6.4. Minerals

6.5. Sugars

6.6. Others

7. GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION

7.1. Overview

7.2. Oral

7.3. Intramuscular

7.4. Subcutaneous

7.5. Transdermal

7.6. Intravenous

7.7. Others

8. GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY

8.1. Overview

8.2. Targeted Delivery

8.3. Microencapsulation

8.4. Wurster Technique

8.5. Others

9. GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Sustained Release Excipients Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Sustained Release Excipients Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2023

10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES

11.1. Allergan PLC

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. AstraZeneca

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. GlaxoSmithKline PLC

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Mayne Pharma Group Limited

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Mylan NV

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Novartis AG

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Pfizer Inc.

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Salix Pharmaceuticals

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Sun Pharmaceutical Industries Ltd.

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 9 US: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 10 US: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 11 US: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 12 CANADA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 13 CANADA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 14 CANADA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 3 EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 5 GERMANY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 6 GERMANY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 7 FRANCE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 8 FRANCE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 9 FRANCE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 10 ITALY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 11 ITALY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 12 ITALY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 13 SPAIN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 14 SPAIN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 15 SPAIN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 16 UK: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 17 UK: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 18 UK: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 25 JAPAN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 26 JAPAN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 27 JAPAN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 28 CHINA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 29 CHINA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 30 CHINA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 31 INDIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 32 INDIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 33 INDIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 34 AUSTRALIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 35 AUSTRALIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 36 AUSTRALIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 49 AFRICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 50 AFRICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 51 AFRICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET

FIGURE 4 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY PRODUCT TYPE, 2023

FIGURE 5 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY ROUTE OF ADMINISTRATION, 2023

FIGURE 6 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY TECHNOLOGY, 2023

FIGURE 7 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 NORTH AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 REST OF THE WORLD: SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 13 ALLERGAN PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 ALLERGAN PLC: SWOT ANALYSIS

FIGURE 15 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 ASTRAZENECA: SWOT ANALYSIS

FIGURE 17 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 GLAXOSMITHKLINE PLC: SWOT ANALYSIS

FIGURE 19 MAYNE PHARMA GROUP LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 MAYNE PHARMA GROUP LIMITED: SWOT ANALYSIS

FIGURE 21 MYLAN NV: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 MYLAN NV: SWOT ANALYSIS

FIGURE 23 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 NOVARTIS AG: SWOT ANALYSIS

FIGURE 25 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 PFIZER INC.: SWOT ANALYSIS

FIGURE 27 SALIX PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 SALIX PHARMACEUTICALS: SWOT ANALYSIS

FIGURE 29 SUN PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 SUN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS